• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗患者心房颤动状态的临床意义

Clinical Significance of Atrial Fibrillation Status in Patients With Percutaneous Coronary Intervention.

作者信息

Hamaguchi Toka, Iwanaga Yoshitaka, Nakai Michikazu, Morita Yusuke, Inoko Moriaki

机构信息

Cardiovascular Center, Tazuke Kofukai Foundation, Medical Research Institute, Kitano Hospital, Osaka, Japan.

Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Suita, Japan.

出版信息

CJC Open. 2021 Jul 6;3(11):1357-1364. doi: 10.1016/j.cjco.2021.06.018. eCollection 2021 Nov.

DOI:10.1016/j.cjco.2021.06.018
PMID:34901804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8640652/
Abstract

BACKGROUND

Patients undergoing percutaneous coronary intervention (PCI) often develop atrial fibrillation (AF). We investigated the clinical effects of AF status on in-hospital mortality and complications in patients with PCI using a recent large-scale nationwide dataset.

METHODS

Using a claims-based dataset from 1022 hospitals in Japan for the time period between 2012 and 2016, patients with PCI were identified and classified into 3 groups according to AF status: no AF, prevalent AF before admission, and incident AF after admission. In-hospital mortality, complications, and medical costs were compared in crude and propensity-matched cohorts.

RESULTS

In 659,525 hospitalized patients undergoing PCI, prevalent AF and incident AF were observed in 6.0% and 1.3% patients, respectively; the AF rates increased over 5 years. A greater proportion of older patients and patients with comorbidities had both of these categories of AF; undergoing PCI for acute coronary syndrome was common in incident AF. Both prevalent AF and incident AF were associated with worse crude outcomes and complications during hospitalization. In propensity-matched cohorts, incident AF was associated with a higher in-hospital mortality rate, longer length of stay, higher direct costs, and higher rate of complications, including stroke and acute kidney injury, compared with prevalent AF. These outcomes, except length of in-hospital stay, did not change for either AF status over 5 years.

CONCLUSIONS

Prevalent AF and incident AF in patients undergoing PCI were both associated with deteriorating crude outcomes and complications; in particular, incident AF was associated with worse adjusted outcomes and complications. Further efforts are needed to improve patient outcomes in an aging society in which the incidence of AF is increasing.

摘要

背景

接受经皮冠状动脉介入治疗(PCI)的患者常发生心房颤动(AF)。我们使用近期大规模全国性数据集,研究了AF状态对PCI患者住院死亡率和并发症的临床影响。

方法

利用日本1022家医院2012年至2016年基于索赔的数据集,识别出PCI患者,并根据AF状态将其分为3组:无AF、入院前存在AF和入院后发生AF。对粗队列和倾向匹配队列中的住院死亡率、并发症和医疗费用进行比较。

结果

在659525例接受PCI的住院患者中,分别有6.0%和1.3%的患者存在入院前AF和入院后AF;AF发生率在5年中有所增加。老年患者和合并症患者中这两类AF的比例更高;急性冠状动脉综合征患者接受PCI在入院后AF中很常见。入院前AF和入院后AF均与住院期间更差的粗结局和并发症相关。在倾向匹配队列中,与入院前AF相比,入院后AF与更高的住院死亡率、更长的住院时间、更高的直接费用以及更高的并发症发生率相关,包括中风和急性肾损伤。除住院时间外这些结局在5年中对任何一种AF状态均无变化。

结论

接受PCI患者的入院前AF和入院后AF均与粗结局和并发症恶化相关;特别是入院后AF与更差的校正结局和并发症相关。在AF发病率不断上升的老龄化社会中,需要进一步努力改善患者结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f04/8640652/8fb746180bd7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f04/8640652/e579b63b069c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f04/8640652/8fb746180bd7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f04/8640652/e579b63b069c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f04/8640652/8fb746180bd7/gr2.jpg

相似文献

1
Clinical Significance of Atrial Fibrillation Status in Patients With Percutaneous Coronary Intervention.经皮冠状动脉介入治疗患者心房颤动状态的临床意义
CJC Open. 2021 Jul 6;3(11):1357-1364. doi: 10.1016/j.cjco.2021.06.018. eCollection 2021 Nov.
2
Temporal trends in prevalence and outcomes of atrial fibrillation in patients undergoing percutaneous coronary intervention.经皮冠状动脉介入治疗患者心房颤动的患病率和结局的时间趋势。
Clin Cardiol. 2020 Jan;43(1):33-42. doi: 10.1002/clc.23285. Epub 2019 Nov 6.
3
Outcomes of Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.接受经皮冠状动脉介入治疗的心房颤动患者的结局。
J Am Coll Cardiol. 2016 Aug 30;68(9):895-904. doi: 10.1016/j.jacc.2016.05.085.
4
Outcomes of Percutaneous Coronary Intervention in Atrial Fibrillation Patients Presenting With Acute Myocardial Infarction: Analysis of Nationwide Inpatient Sample Database.经皮冠状动脉介入治疗在急性心肌梗死伴心房颤动患者中的疗效分析:全国住院患者样本数据库分析。
Cardiovasc Revasc Med. 2020 Jul;21(7):851-854. doi: 10.1016/j.carrev.2019.12.011. Epub 2019 Dec 6.
5
Outcomes of Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Analysis of National Inpatient Sample.接受经皮冠状动脉介入治疗的心房颤动患者的结局:全国住院患者样本分析
Cardiovasc Revasc Med. 2020 Jan;21(1):14-19. doi: 10.1016/j.carrev.2019.03.008. Epub 2019 Mar 14.
6
The Impact of Atrial Fibrillation on In-Hospital Outcomes in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Coronary Revascularization with Percutaneous Ventricular Assist Device Support.心房颤动对急性心肌梗死合并心源性休克且接受经皮心室辅助装置支持的冠状动脉血运重建患者住院结局的影响。
J Atr Fibrillation. 2020 Feb 28;12(5):2179. doi: 10.4022/jafib.2179. eCollection 2020 Feb-Mar.
7
Percutaneous Coronary Intervention Outcomes Among Patients With Alcoholic Cardiomyopathy: An Analysis of the National Inpatient Sample.酒精性心肌病患者经皮冠状动脉介入治疗的结果:基于全国住院患者样本的分析
Cureus. 2022 Sep 23;14(9):e29490. doi: 10.7759/cureus.29490. eCollection 2022 Sep.
8
Adverse 30-Day Clinical Outcomes and Long-Term Mortality Among Patients With Preprocedural Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.经皮冠状动脉介入治疗术前合并心房颤动患者的 30 天临床预后不良和长期死亡率。
Heart Lung Circ. 2022 May;31(5):638-646. doi: 10.1016/j.hlc.2021.12.013. Epub 2022 Feb 4.
9
Prevalence and Determinants of Atrial Fibrillation-Associated In-Hospital Ischemic Stroke in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.接受经皮冠状动脉介入治疗的急性心肌梗死患者中,房颤相关院内缺血性卒中的患病率及决定因素
Am J Cardiol. 2021 Apr 1;144:1-7. doi: 10.1016/j.amjcard.2020.12.066. Epub 2020 Dec 29.
10
Current status of percutaneous coronary intervention in patients with atrial fibrillation: The Fushimi AF Registry.心房颤动患者经皮冠状动脉介入治疗的现状:伏见 AF 注册研究。
J Cardiol. 2020 May;75(5):513-520. doi: 10.1016/j.jjcc.2019.09.014. Epub 2019 Nov 3.

本文引用的文献

1
Complications Associated With Catheter Ablation in Patients With Atrial Fibrillation: A Report From the JROAD-DPC Study.房颤患者导管消融相关并发症:JROAD-DPC 研究报告。
J Am Heart Assoc. 2021 Jun;10(11):e019701. doi: 10.1161/JAHA.120.019701. Epub 2021 May 27.
2
Validation of Acute Myocardial Infarction and Heart Failure Diagnoses in Hospitalized Patients With the Nationwide Claim-Based JROAD-DPC Database.利用全国基于索赔的JROAD-DPC数据库对住院患者急性心肌梗死和心力衰竭诊断进行验证
Circ Rep. 2021 Feb 20;3(3):131-136. doi: 10.1253/circrep.CR-21-0004.
3
Trends in Prevalence of Non-Valvular Atrial Fibrillation and Anticoagulation Therapy in a Japanese Region - Analysis Using the National Health Insurance Database.
日本某地区非瓣膜性心房颤动患病率及抗凝治疗趋势分析——基于国民健康保险数据库的研究
Circ J. 2020 Apr 24;84(5):706-713. doi: 10.1253/circj.CJ-18-0989. Epub 2020 Mar 25.
4
Temporal trends in prevalence and outcomes of atrial fibrillation in patients undergoing percutaneous coronary intervention.经皮冠状动脉介入治疗患者心房颤动的患病率和结局的时间趋势。
Clin Cardiol. 2020 Jan;43(1):33-42. doi: 10.1002/clc.23285. Epub 2019 Nov 6.
5
Site Variation and Outcomes for Antithrombotic Therapy in Atrial Fibrillation Patients After Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后心房颤动患者抗栓治疗的部位差异和结局。
Circ Cardiovasc Interv. 2019 Aug;12(8):e007604. doi: 10.1161/CIRCINTERVENTIONS.118.007604. Epub 2019 Aug 16.
6
Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study.经皮冠状动脉介入治疗的亚洲心房颤动患者的患病率和抗血栓治疗的时间趋势:一项全国性的韩国基于人群的研究。
PLoS One. 2019 Jan 15;14(1):e0209593. doi: 10.1371/journal.pone.0209593. eCollection 2019.
7
Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study.根据最佳、临界或升高水平的危险因素,预测心房颤动的终生风险:基于弗雷明汉心脏研究纵向数据的队列研究。
BMJ. 2018 Apr 26;361:k1453. doi: 10.1136/bmj.k1453.
8
Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.药物洗脱冠状动脉支架置入患者的房颤患病率、治疗及 6 年随访结果。
JACC Cardiovasc Interv. 2017 Jun 12;10(11):1075-1085. doi: 10.1016/j.jcin.2017.02.028. Epub 2017 May 17.
9
Validity of diagnoses, procedures, and laboratory data in Japanese administrative data.日本行政数据中诊断、程序和实验室数据的有效性。
J Epidemiol. 2017 Oct;27(10):476-482. doi: 10.1016/j.je.2016.09.009. Epub 2017 Jan 27.
10
The Current Status of Cardiovascular Medicine in Japan - Analysis of a Large Number of Health Records From a Nationwide Claim-Based Database, JROAD-DPC.日本心血管医学的现状——基于全国性索赔数据库JROAD-DPC的大量健康记录分析
Circ J. 2016 Oct 25;80(11):2327-2335. doi: 10.1253/circj.CJ-16-0196. Epub 2016 Oct 5.